<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOph</journal-id><journal-title-group><journal-title>Open Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="epub">2165-7408</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojoph.2023.133027</article-id><article-id pub-id-type="publisher-id">OJOph-126667</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Ten Years of Epidemiological and Diagnostic Aspects of Non-Traumatic Anterior Uveitis at Campus Teaching Hospital of Lome-Togo
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nidain</surname><given-names>Maneh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adakou</surname><given-names>Aimée Victoire Abaglo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bénédicte</surname><given-names>Marèbe Diatewa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kanfiaguin</surname><given-names>Boundja</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yawa</surname><given-names>Ebeva Nagbe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mawuli</surname><given-names>Ayodele Komi Santos</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kokou</surname><given-names>Vonor</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kokou</surname><given-names>Messan Amedome</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Didier</surname><given-names>Koffi Ayena</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Ophthalmology Department, University of Lome, Lome, Togo</addr-line></aff><aff id="aff2"><addr-line>Ophthalmology Department, Teaching Hospital (CHU) Campus, Lome, Togo</addr-line></aff><aff id="aff3"><addr-line>Ophthalmology Department, University of Kara, Kara, Togo</addr-line></aff><pub-date pub-type="epub"><day>21</day><month>06</month><year>2023</year></pub-date><volume>13</volume><issue>03</issue><fpage>280</fpage><lpage>287</lpage><history><date date-type="received"><day>23,</day>	<month>June</month>	<year>2023</year></date><date date-type="rev-recd"><day>25,</day>	<month>July</month>	<year>2023</year>	</date><date date-type="accepted"><day>28,</day>	<month>July</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Uveitis is a serious disease which dangerous complications can jeopardize the visual prognosis. Anterior uveitis (AU) is the inflammation of the anterior uvea which is composed of the iris and the ciliary body. The objective of the study was to identify the epidemiological and etiological determinants of non-traumatic anterior uveitis at the Campus Teaching Hospital of Lom&#233;. 
  Materials and methods: Retrospective cross-sectional study of the records of patients diagnosed with anterior uveitis (AU) without a notion of trauma in the ophthalmology department of CHU Campus of Lom&#233; from January 1, 2010 to December 31, 2019 (10 years). 
  Results: 141 cases of uveitis, representing a prevalence of 0.18%. Female predominance, with a sex ratio of 0.76. Mean age was 34.74 &#177; 13.20 years. Decreased visual acuity was the primary complaint (34.40%), followed by ocular pain (28%). Non-traumatic anterior uveitis was unilateral in 87.2% of cases. Retro-corneal precipitates were present in all patients. 61.60% of patients had Tyndall in the anterior chamber. The etiology of non-traumatic AU was undetermined in 76.80% of cases. Toxoplasmosis, tuberculosis and syphilis were the main etiologies found. 
  Conclusion: Non-traumatic anterior uveitis is relatively rare but serious, often affecting young subjects. It is a pathology that engages eye health professionals, not only because of the difficulties involved in diagnosing the etiology, but also because of its progression which sometimes leads to blindness.
 
</p></abstract><kwd-group><kwd>Anterior Uveitis</kwd><kwd> Non-Traumatic</kwd><kwd> Epidemiology</kwd><kwd> Etiology</kwd><kwd> Lome</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Uveitis is a serious disease which dangerous complications can jeopardize the visual prognosis. Uveitis refers to the inflammation of the uveal tract, which is the middle vascular coat of the eye, lying between the sclera and neuro-epithelium [<xref ref-type="bibr" rid="scirp.126667-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref2">2</xref>] . Uveitis is a rare but serious disease, with an estimated incidence of 17/100,000 in France [<xref ref-type="bibr" rid="scirp.126667-ref3">3</xref>] . Anterior uveitis (AU) is the inflammation of the anterior uvea which is composed of the iris and the ciliary body. The inflammation can affect either the iris (iritis), the ciliary body (cyclitis) or both (iridocyclitis). Studies of anterior uveitis in the sub-region have reported respective prevalence of 0.85% and 1.35% [<xref ref-type="bibr" rid="scirp.126667-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref5">5</xref>] .</p><p>The anatomical characterization of uveitis, its scalability mode and whether it is unilateral or bilateral are therefore essential for relevant diagnostic and therapeutic orientation [<xref ref-type="bibr" rid="scirp.126667-ref6">6</xref>] . The diversity of etiologies of non-traumatic anterior uveitis represents a real diagnostic and therapeutic challenge in our practice setting. Although much African research has been published on uveitis, to our knowledge few are dedicated to non-traumatic anterior uveitis [<xref ref-type="bibr" rid="scirp.126667-ref7">7</xref>] . The objective of this study was to identify the epidemiological and diagnostic determinants of non-traumatic anterior uveitis at the Campus teaching hospital (CHU) of Lome.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This ten year’s retrospective cross-sectional study from January 1, 2010, to December 31, 2019, included the records of all patients who consulted the ophthalmology department of the CHU Campus of Lome and who had a diagnosis of non-traumatic anterior uveitis. The records that did not contain all the data were excluded from the study. CHU Campus of Lome is one of Togo’s three reference hospitals. We obtained authorization from the Director of the CHU Campus to conduct the study. The study complied with the ethical principles set out in the Declaration of Helsinki. For each patient, the following data were collected from the consultation register and medical record:</p><p>• demographic data (age, sex);</p><p>• reason for consultation, onset, duration;</p><p>• physical signs (retro-corneal precipitates, Tyndall effects, hypopyon);</p><p>• biological tests and imaging;</p><p>• etiological diagnosis.</p><p>Operational definitions</p><p>• Tyndall in the anterior chamber: the presence of inflammatory proteins and cells circulating in the aqueous humor [<xref ref-type="bibr" rid="scirp.126667-ref8">8</xref>] .</p><p>• Sarcoidosis was based on the granulomatous appearance of the eye damage associated with constant tuberculin anergy and other illustrative manifestations, in particular inflammatory arthralgias, and the presence of hilar and mediastinal adenopathies on chest CT scan.</p><p>• Tuberculosis was considered on the basis of a positive intradermal tuberculin test, HIV immunosuppression, radiographic injuries in favor of pulmonary tuberculosis and granulomatous uveitis.</p><p>Qualitative variables were expressed as a number of cases and percentages and quantitative values as mean (&#177;standard deviation).</p></sec><sec id="s3"><title>3. Results</title><p>One hundred and twenty-five patients (141 eyes) out of 68,779 seen in consultation presented non-traumatic anterior uveitis, representing a prevalence of 0.18%.</p><p>The mean age of patients was 34.74 &#177; 13.20 years [11 years; 64 years] and the female gender was predominant with a sex ratio of 0.76 (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Decreased visual acuity (VA), eye pain and blurred vision were the main reasons for consultation in respectively 34.40%, 28% and 20% of cases. (<xref ref-type="table" rid="table2">Table 2</xref>)</p><p>Non-traumatic anterior uveitis had a progressive onset in 57.20% of cases, and a brutal onset in 42.80%. Single episodes of non-traumatic anterior uveitis accounted for 89.60% of cases. Non-traumatic AU was unilateral in 87.20% of cases, including 49.60% in the right eye (RE) and 37.60% in the left eye (LE). Vision was low in the majority of cases, with uncorrected visual acuity (VA) between 1/10 and 3/10 in 43.26% of cases (<xref ref-type="table" rid="table3">Table 3</xref>). Retro-corneal precipitates (RCP) were found in all eyes, and Tyndall in the anterior chamber in 54.60% of cases (<xref ref-type="table" rid="table4">Table 4</xref>). According to the anatomical and clinical characteristics, retro-corneal precipitates were predominantly grayish in 58.86%, granulomatous in 29.08% and non-granulomatous in 17.02% of cases. (<xref ref-type="table" rid="table5">Table 5</xref>)</p><p>A biological inflammatory syndrome was noted in 28 cases (22.4%), with a consistently high C-reactive protein (CRP), above 6 mg/l, and a sedimentation rate (ESR) greater than 20 millimeters in the first hour in 33 cases (26.4%). HIV retroviral, toxoplasma and TPHA VDRL serologies were positive in respectively 8.8%, 2.4% and 1.6% of cases. Intradermal tuberculin testing was performed in 44.8% of patients, with 4% positive.</p><p>The presence of hilar and median adenopathies illustrating sarcoidosis detected on chest CT (2 cases) and radiographic lesions in favor of pulmonary tuberculosis (1 case) were noted. Cerebral toxoplasmosis was noticed in 5 cases (4%) after the brain CT scan.</p><p>The etiology of non-traumatic anterior uveitis was undetermined in 73.60% of cases. Infectious causes represented 17.60%, dominated by ocular toxoplasmosis in 10.40% and inflammatory causes in 8.8% of cases. (<xref ref-type="table" rid="table6">Table 6</xref>)</p></sec><sec id="s4"><title>4. Discussion</title><p>Over a ten years period, 141 cases of non-traumatic anterior uveitis were reported at the ophthalmology department of the CHU Campus of Lome. Non-traumatic anterior uveitis was predominantly unilateral, and infections were the most important etiologies in 17.60% of cases.</p><p>The prevalence of 0.18% in this study were lower than those of Assavedo et al., and Sounouvou et al., on uveitis in Benin, who reported respectively 1.35% and</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Patient distribution by age and gender</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Gender</th><th align="center" valign="middle"  rowspan="2"  >Total</th><th align="center" valign="middle"  rowspan="2"  >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >Male</td></tr><tr><td align="center" valign="middle" >[11 - 21 years[</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >15,20</td></tr><tr><td align="center" valign="middle" >[21 - 31 years[</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >28.80</td></tr><tr><td align="center" valign="middle" >[31 - 41 years[</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >20.80</td></tr><tr><td align="center" valign="middle" >[41 - 51 years[</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >20.00</td></tr><tr><td align="center" valign="middle" >[51 - 60 years[</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >12.80</td></tr><tr><td align="center" valign="middle" >≥60 years</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.40</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >125</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients by reason for consultation</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Headcount</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >DVA*<sup> </sup></td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >34.40</td></tr><tr><td align="center" valign="middle" >Eye pain</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >28.00</td></tr><tr><td align="center" valign="middle" >Visual blur</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >20.00</td></tr><tr><td align="center" valign="middle" >Tearing</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >4.80</td></tr><tr><td align="center" valign="middle" >Photophobia</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >4.80</td></tr><tr><td align="center" valign="middle" >Ocular redness</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >4.80</td></tr><tr><td align="center" valign="middle" >Others<sup>+ </sup></td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.20</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >125</td><td align="center" valign="middle" >100.00</td></tr></tbody></table></table-wrap><p>*Decrease in visual acuity; <sup>+</sup>Sensation of foreign body, ocular heaviness, ocular discomfort.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Eye distribution by visual acuity</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="2"  >OD</th><th align="center" valign="middle"  colspan="2"  >OG</th><th align="center" valign="middle"  colspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >n*</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >n*</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >n*</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >VA<sup>+</sup> &lt; 1/10</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >26.62</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >35.48</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >30.50</td></tr><tr><td align="center" valign="middle" >1/10 ≤ VA<sup>+</sup> &lt; 3/10</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >45.57</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >40.32</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >43.26</td></tr><tr><td align="center" valign="middle" >≥3/10</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >39.24</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >24.19</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >25.53</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >62</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >141</td><td align="center" valign="middle" >100.00</td></tr></tbody></table></table-wrap><p>*Headcount; <sup>+</sup>Visual acuity.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Physical signs of non-traumatic anterior uveitis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Headcount</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >RCP*<sup> </sup></td><td align="center" valign="middle" >141</td><td align="center" valign="middle" >100.00</td></tr><tr><td align="center" valign="middle" >Tyndall in AC<sup>+ </sup></td><td align="center" valign="middle" >77</td><td align="center" valign="middle" >54.60</td></tr><tr><td align="center" valign="middle" >High IOP<sup>++</sup></td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >26.24</td></tr><tr><td align="center" valign="middle" >Synechia</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >19.86</td></tr><tr><td align="center" valign="middle" >Hypopyon</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.13</td></tr><tr><td align="center" valign="middle" >Irial nodules (Koeppe, bussaca)</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.13</td></tr></tbody></table></table-wrap><p>*Retro-corneal precipitates; <sup>+</sup>Anterior chamber; <sup>++</sup>Intraocular pression.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Anatomo-clinical characteristics of retro-corneal precipitates</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Headcount</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Color</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Pigmented</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >21.98</td></tr><tr><td align="center" valign="middle" >Greyish</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >58.86</td></tr><tr><td align="center" valign="middle" >Whitish</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >7.80</td></tr><tr><td align="center" valign="middle" >Size</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Fine</td><td align="center" valign="middle" >76</td><td align="center" valign="middle" >53.90</td></tr><tr><td align="center" valign="middle" >Medium</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >13.47</td></tr><tr><td align="center" valign="middle" >Large</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >21.28</td></tr><tr><td align="center" valign="middle" >Granulomatous character</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >29.08</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >17.02</td></tr><tr><td align="center" valign="middle" >Undetermined</td><td align="center" valign="middle" >76</td><td align="center" valign="middle" >53.90</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Causes of non-traumatic anterior uveitis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Headcount</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Inflammatory</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >8.80</td></tr><tr><td align="center" valign="middle" >Sarcoidosis</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.20</td></tr><tr><td align="center" valign="middle" >Ankylosing spondylitis</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4.00</td></tr><tr><td align="center" valign="middle" >Juvenile idiopathic arthritis</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.60</td></tr><tr><td align="center" valign="middle" >Infectious</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >17.60</td></tr><tr><td align="center" valign="middle" >Toxoplasmosis</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >10.40</td></tr><tr><td align="center" valign="middle" >Tuberculosis</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5.60</td></tr><tr><td align="center" valign="middle" >Syphilis</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.60</td></tr><tr><td align="center" valign="middle" >Undetermined</td><td align="center" valign="middle" >92</td><td align="center" valign="middle" >73.60</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >125</td><td align="center" valign="middle" >100.00</td></tr></tbody></table></table-wrap><p>0.65% [<xref ref-type="bibr" rid="scirp.126667-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref10">10</xref>] . This low prevalence may be explained by the fact that, unlike other studies, the study only took into account anterior non-traumatic uveitis. The mean age of patients was 34.74 &#177; 13.20 years. This is lower than those of Assavedo et al., and Nguyen et al., who found respectively 38.4 and 47.2 years [<xref ref-type="bibr" rid="scirp.126667-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref11">11</xref>] . It is similar to that of Ayena et al., [<xref ref-type="bibr" rid="scirp.126667-ref12">12</xref>] who reported an age average of 35.7 years. The age group between 21 and 31 years was the most represented, with 28.80% of cases. Koffi et al., and Chung et al., found an age range of 21 - 40 years [<xref ref-type="bibr" rid="scirp.126667-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref14">14</xref>] . These results confirm the observations that uveitis can occur at any age, particularly between the ages of 20 and 60 [<xref ref-type="bibr" rid="scirp.126667-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref16">16</xref>] .</p><p>A female predominance was noticed with a sex ratio of 0.76. A male predominance is often reported in the literature, with a sex ratio ranging from 1.1 to 1.5 [<xref ref-type="bibr" rid="scirp.126667-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref17">17</xref>] . The difference in percentage according to sex could be explained by methodological variability in the different studies.</p><p>Non-traumatic AU was unilateral in 87.2% of cases. This result is higher than that of Souley et al., who reported 60.95% of unilateral uveitis in a study of the epidemiological profile of uveitis in Morocco, and that of Maalouf et al., (56.8%) [<xref ref-type="bibr" rid="scirp.126667-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref19">19</xref>] . All these studies show that anterior uveitis is often unilateral. Visual acuity tests during the ophthalmological examination showed that all patients presented a decrease in visual acuity. This corroborates the findings of most authors, who have identified decreased visual acuity as one of the frequent signs of anterior uveitis [<xref ref-type="bibr" rid="scirp.126667-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.126667-ref19">19</xref>] .</p><p>The slit-lamp examination of the patients revealed that retro-corneal precipitates (RCP) were the main clinical sign in all cases. This result is higher than that of Ayena et al., [<xref ref-type="bibr" rid="scirp.126667-ref12">12</xref>] who found 65.5% RCP. This confirms that RCP is one of the cardinal physical signs of anterior uveitis. It should be noted that 29.60% of patients showed a high intraocular pressure. This result is higher than that of Chebil et al., [<xref ref-type="bibr" rid="scirp.126667-ref20">20</xref>] who reported 12% of high intraocular pressure in a study conducted in Tunisia about the epidemiology of uveitis.</p><p>The etiological approach and the request for additional examinations in non-traumatic anterior uveitis must take into account the clinical features and extra-ophthalmological manifestations, hence the importance of close collaboration between the ophthalmologist and the internist. The poor technical equipment limits the etiological research of non-traumatic AU. However, a minimum check-up consisting of blood count, C-reactive protein (CRP), toxoplasmosis serology, tuberculin skin test (TST) and syphilis serology was requested. The etiologies of non-traumatic anterior uveitis in this series were dominated by toxoplasmosis (10.40%), and tuberculosis (5.60%). Causes were undetermined in 76.80% of cases. Ayena et al. [<xref ref-type="bibr" rid="scirp.126667-ref12">12</xref>] found toxoplasmosis (7.5%), and shingles (3.2%), followed by HIV (2.6%) and undetermined causes in 85.7% of cases. Chebil et al. [<xref ref-type="bibr" rid="scirp.126667-ref20">20</xref>] reported Beh&#231;et’s disease (14.7%), toxoplasmosis (10.2%), Vogt-Koyanagi-Harada (VKH) (3.7%) and sarcoidosis (3.3%) as causes of anterior uveitis. These results show a wide diversity of etiological distribution from one series to another. This diversity of etiologies could be linked to genetic and socio-economic factors.</p></sec><sec id="s5"><title>5. Limitations</title><p>One of the limitations of the study it was a retrospective cohort and patient examination was done by different personnel. The absence of anterior chamber puncture for biological examinations in the etiological research was another limitation of this study. However, the long period of 10 years enabled to obtain a substantial sample of 141 cases of non-traumatic anterior uveitis is an asset of the study.</p></sec><sec id="s6"><title>6. Conclusion</title><p>A retrospective cross-sectional study of non-traumatic anterior uveitis over a ten years period revealed a prevalence of 0.18%. It remains a rare but serious pathology and a cause of blindness. Non-traumatic anterior uveitis mainly affects young people with decreased visual acuity as the first reason for consultation. In most cases, the etiologies are undetermined, and when found, they are dominated by infectious causes, in particular toxoplasmosis and tuberculosis. The etiological approach must therefore be contextual and multidisciplinary, taking into account above all the clinical presentation in front of poor technical equipment. Further studies on the etiological research coupled with the therapeutic may provide a complete understanding of the particularities of non-traumatic anterior uveitis in sub-Saharan Africa.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="s8"><title>Cite this paper</title><p>Maneh, N., Abaglo, A.A.V., Diatewa, B.M., Boundja, K., Nagbe, Y.E., Santos, M.A.K., Vonor, K., Amedome, K.M. and Ayena, D.K. (2023) Ten Years of Epidemiological and Diagnostic Aspects of Non-Traumatic Anterior Uveitis at Campus Teaching Hospital of Lome-Togo. Open Journal of Ophthalmology, 13, 280-287. https://doi.org/10.4236/ojoph.2023.133027</p></sec></body><back><ref-list><title>References</title><ref id="scirp.126667-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Yanoff, M. and Duker, J.S. (2008) Ophthalmology. 3rd Edition, Elsevier, St. Louis.</mixed-citation></ref><ref id="scirp.126667-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Bowling, B. (2016) Kanski’s Clinical Ophthalmology. 8th Edition, Elsevier Limited, Sydney.</mixed-citation></ref><ref id="scirp.126667-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Bonnet, C. and Brezin, A. (2020) Uvéites, éléments d’orientation diagnostique. Journal Fran&amp;#231;ais d’Ophtalmologie, 43, 145-151. https://doi.org/10.1016/j.jfo.2019.03.038</mixed-citation></ref><ref id="scirp.126667-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Moussala, M., Missipo, N.O. and Keutchemou, P. (1989) La pathologie oculaire dans l’Ouest Cameroun. Médecine d’Afrique Noire, 36, 857-860.</mixed-citation></ref><ref id="scirp.126667-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Suttorp-Schutten, M.S. and Rothova, A. (1996) The Possible Impact of Uveitis in Blindness a Literature Survey. British Journal of Ophthalmology, 80, 844-848. https://doi.org/10.1136/bjo.80.9.844</mixed-citation></ref><ref id="scirp.126667-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Gueudry, J. and Muraine, M. (2018) Uvéites antérieures. Journal Fran&amp;#231;ais d’Ophtalmologie, 41, e11-e21. https://doi.org/10.1016/j.jfo.2017.06.012</mixed-citation></ref><ref id="scirp.126667-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Moussala, M., Kouda Zeh, A., Machia, S., Bitang, L.J., Mc Moli, T.E. and Moukouri, E. (1997) Les uvéites en milieu camerounais (à propos de 55 patients étudiés à Yaoundé): Formes cliniques selon le siège et retentissement fonctionnel. Médecine d’Afrique Noire, 44, 331-333.</mixed-citation></ref><ref id="scirp.126667-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Jabs, A.D., Nussenblatt, B.R., Rosenbaum, J.J. and Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop. American Journal of Ophthalmology, 140, 509-516. https://doi.org/10.1016/j.ajo.2005.03.057</mixed-citation></ref><ref id="scirp.126667-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Assavedo, R., Tchabi, S., Abdoulaye, H. and Doutetien, C. (2014) Aspects épidémio-logiques et cliniques des uvéites. Revue SOAO, 2, 7-11.</mixed-citation></ref><ref id="scirp.126667-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Sounouvou, I., Tchabi, S., Doutretien, C., Deguenon, J., Yehouessi, L. and Bassabi, S.K. (2004) Les uvéites au centre national hospitalier universitaire de Cotonou. Le Benin Médical, 28, 19-33.</mixed-citation></ref><ref id="scirp.126667-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Nguyen, A.-M., Sève, P., Le Scanff, J., Gambrelle, J., Fleury, J., Broussolle, C., et al. (2011) Aspects cliniques et étiologiques des uvéites: Etude rétrospective de 121 patients adressés à un centre tertiaire d’ophtalmologie. La Revue de Médecine Interne, 32, 9-16. https://doi.org/10.1016/j.revmed.2010.07.020</mixed-citation></ref><ref id="scirp.126667-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Ayena, D., Assavedo, D., Nagbe, E., Zonvide, D., Amedome, M., Tete, Y., et al. (2017) Profil épidémiologique, clinique et thérapeutique des uvéites à Boko et à Parakou au nord du Bénin. Revue SOAO, 1, 49-54.</mixed-citation></ref><ref id="scirp.126667-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Koffi, K.V., Kouassi, A.C., Effi, H., Safede, K. and Keita, C.T. (2001) Les uvéites: Profil épidémiologique, clinique et thérapeutique au CHU Cocody (Abidjan-Cote d’Ivoire). Médecine d’Afrique Noire, 48, 67-72.</mixed-citation></ref><ref id="scirp.126667-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Chung, H. and Choi, D.G. (1989) Clinical Analysis of Uveitis. Korean Journal of Ophthalmology, 3, 33-37. https://doi.org/10.3341/kjo.1989.3.1.33</mixed-citation></ref><ref id="scirp.126667-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Wakefield, D. and Chang, J. (2005) Epidemiology of Uveitis. International Ophthalmology Clinics, 45, 1-13. https://doi.org/10.1097/01.iio.0000155938.83083.94</mixed-citation></ref><ref id="scirp.126667-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Darrell, R.W., Wagner, H.P. and Kurland, L.T. (1962) Epidemiology of Uveitis. Archives of Ophthalmology, 68, 502-515. https://doi.org/10.1001/archopht.1962.00960030506014</mixed-citation></ref><ref id="scirp.126667-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Levecq, L., Disneur, D., Dutrieux, C. and Snyers, B. (1999) Etiologies of Intermediate, Posterior, and Panvuveitis: A Review of 201 Cases. Bulletin de la Societe Belge d’Ophtalmologie, 273, 9-14.</mixed-citation></ref><ref id="scirp.126667-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Souley, A.S.Y., Abdellah, H.O.M., Khmamouche, M., Naji, A.A., Elasri, E.O.N.F., Reda, K., et al. (2016) Profil épidémiologique des uvéites à propos de 105 cas. The Pan African Medical Journal, 27, Article No. 97. https://doi.org/10.11604/pamj.2016.24.97.9188</mixed-citation></ref><ref id="scirp.126667-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Maalouf, Z., Osta, F., Haddad, G. and Maalouly, G. (2017) Uvéites: Aspects cliniques et étiologiques. La Revue de Médecine Interne, 38, 145-146. https://doi.org/10.1016/j.revmed.2017.10.081</mixed-citation></ref><ref id="scirp.126667-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Chebil, A., Baroudi, B., Slim, M., Cheiker, N., Lamloum, M., Bouladi, M., et al. (2013) Profil épidémiologique des uvéites dans la région de Tunis. Journal Fran&amp;#231;ais d’Ophtalmologie, 36, 764-768. https://doi.org/10.1016/j.jfo.2013.05.006</mixed-citation></ref></ref-list></back></article>